Opiant Pharmaceuticals, Inc.
OPNT · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $149,855 | $34,128 | $57,859 | $43,133 |
| - Cash | $37,854 | $48,251 | $30,980 | $24,614 |
| + Debt | $17,080 | $18,983 | $772 | $0 |
| Enterprise Value | $129,081 | $4,859 | $27,650 | $18,520 |
| Revenue | $40,725 | $27,402 | $38,236 | $13,513 |
| % Growth | 48.6% | -28.3% | 183% | – |
| Gross Profit | $31,659 | $21,205 | $30,516 | $12,022 |
| % Margin | 77.7% | 77.4% | 79.8% | 89% |
| EBITDA | $5,829 | -$1,548 | $11,149 | -$21,141 |
| % Margin | 14.3% | -5.6% | 29.2% | -156.4% |
| Net Income | $3,009 | -$1,861 | $11,593 | -$21,195 |
| % Margin | 7.4% | -6.8% | 30.3% | -156.8% |
| EPS Diluted | 0.51 | -0.44 | 2.17 | -7.1 |
| % Growth | 215.9% | -120.3% | 130.6% | – |
| Operating Cash Flow | $1,926 | -$2,029 | $4,064 | -$523 |
| Capital Expenditures | $0 | -$51 | -$302 | $0 |
| Free Cash Flow | $1,926 | -$2,080 | $3,761 | -$523 |